Dexamethasone intravitreal implant: An effective adjunctive treatment for recalcitrant noninfectious uveitis

Ophthalmologica

Volumn 228, Issue 4, 2012, Pages 229-233

  Miserocchi, E ^a   Modorati, G ^a   Pastore, M R ^a   Bandello, F ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Corticosteroids; Intravitreal dexamethasone; Macular edema; Uveitis

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MALE; RECALCITRANT NONINFECTIOUS UVEITIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEITIS, POSTERIOR; VISUAL ACUITY;

EID: 84867986975     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000343060     Document Type: Article

References (17)

1. Suttorp-Schulten MS, Rothova A: The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996; 80: 844-848. (Pubitemid 26345317)
2. Nussenblatt RB: The natural history of uveitis. Int Ophthalmol 1990; 14: 303-308. (Pubitemid 20350862)
3. Miserocchi E, Modorati G, Foster CS: New treatments in noninfectious uveitis; in Bandello F (eds): Developments in Ophthalmology. Basel, Karger, vol 51, pp 134-161.
4. Larson T, Nussenblatt RB, Sen HN: Emerging drugs for uveitis. Expert Opin Emerg Drugs 2011; 16: 309-322.
5. Sherif Z, Pleyer U: Corticosteroids in ophthalmology: past-present-future. Ophthalmologica 2002; 216:305-315.
6. Taylor SR, Isa H, Joshi L, Lightman S: New developments in corticosteroid therapy for uveitis. Ophthalmologica 2010; 224: 46-53.
7. Cunningham ET Jr, Wender JD: Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol 2010; 45: 352-358.
8. Edelman JL: Differentiating intraocular glucocorticoids. Ophthalmologica 2010; 224: 25-30.
9. Callanan DG, Jaffe GJ, Martin DF, Pearson PA, Comstock TL: Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol 2008; 126: 1191-1201.
10. Ghosn CR, Li Y, Orilla WC, Lin T, Wheeler L, Burke JA, Robinson MR, Whitcup SM: Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 2011; 52: 2917-2923.
11. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM: Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011; 118: 2453-2460.
12. Yeh WS, Haller JA, Lanzetta P, Kuppermann BD, Wong TY, Mitchell P, Whitcup SM, Kowalski JW: Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012; 119: 1190-1198.
13. Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM: Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011; 129: 545-553.
14. Myung JS, Aaker GD, Kiss S: Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant. Clin Ophthalmol 2010; 4: 1423-1426.
15. Williams GA, Haller JA, Kuppermann BD, Blumenkranz MS, Weinberg DV, Chou C, Whitcup SM: Dexamethasone posteriorsegment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol 2009; 147: 1048-1054.
16. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509-516. (Pubitemid 41224845)
17. Saraiya NV, Patel SS, Goldstein DA: A report of high intraocular pressure with the dexamethasone intravitreal implant. Arch Ophthalmol 2011; 129: 1638-1639.